Verdict · sk:energy

Is Urolithin A (Mitopure) worth it?

IN

Urolithin A has a real human signal, but it is narrow: older-adult muscle endurance and mitochondrial-health biomarkers, not instant energy or longevity insurance. The price only makes sense if the target is muscle function in an aging context after protein, creatine, and training basics are already handled. Pomegranate and walnut polyphenols are not the same as a standardized urolithin A dose.

The call

Urolithin A is one of the few mitochondrial-positioned supplements with randomized human data beyond mechanism. A first-in-human trial found bioavailability, tolerability, and changes in mitochondrial gene-expression and acylcarnitine biomarkers after 500-1000 mg/day in sedentary older adults. A later randomized clinical trial in older adults found improved muscle endurance and favorable biomarker movement, while the primary 6-minute walk and maximal ATP-production outcomes were not significantly improved versus placebo. That earns a cautious mixed keep for a specific older-adult muscle-endurance use case, not for general energy, fat loss, lifespan extension, or broad mitochondrial marketing.

Safety

Short-term adult trials found urolithin A generally well tolerated, but long-term safety, pregnancy safety, breastfeeding safety, pediatric safety, and safety in serious chronic disease are not established. Avoid during pregnancy and breastfeeding, and avoid use in children unless medically supervised. Use clinician review with cancer, immune disorders, liver disease, kidney disease, recent major cardiac events, frailty, or complex medication regimens. Possible issues include gastrointestinal upset, abnormal lab findings, allergy, or unexpected changes in exercise tolerance; stop if rash, severe GI symptoms, chest pain, fainting, unusual weakness, or concerning lab changes occur.

Dose that matters: 500-1000 mg/day urolithin A; the clearest muscle-endurance RCT used 1000 mg/day for 4 months in older adults. Take consistently with food and reassess function rather than treating it as a permanent energy supplement.

Sources

Tier 2 · evidence synthesis · Reviewed by the Stack-kit desk

Audit your whole shelf →   See all verdicts →

Goals